Sign In
Buy MORF
$56.99
+0 (+0%)
At Close: Nov 14, 2024
MORF Stock Price: $103 Target (Up From $40) By Wells Fargo
06:31am, Sunday, 07'th Mar 2021
The shares of Morphic Holding Inc (NASDAQ: MORF) have received a price target increase from $40 to $103 by Wells Fargo. These are the details.
Morphic Therapeutic Announces Pricing of Upsized $245.0 Million Public Offering
08:25pm, Tuesday, 02'nd Mar 2021
WALTHAM, Mass., March 02, 2021 (GLOBE NEWSWIRE) -- Morphic Holding, Inc. (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious
Why Morphic Holding Stock Is Falling Today
11:25am, Tuesday, 02'nd Mar 2021
The company announced a proposed public offering of common stock.
Morphic Therapeutic Announces Proposed Public Offering
04:01pm, Monday, 01'st Mar 2021
WALTHAM, Mass., March 01, 2021 (GLOBE NEWSWIRE) -- Morphic Holding, Inc. (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious
Morphic Holding, Inc. (MORF) CEO Praveen Tipirneni on Q4 2020 Results - Earnings Call Transcript
02:28pm, Monday, 01'st Mar 2021
Morphic Holding, Inc. (MORF) CEO Praveen Tipirneni on Q4 2020 Results - Earnings Call Transcript
Why Morphic Holding Stock Is Skyrocketing Today
01:33pm, Monday, 01'st Mar 2021
A series of positive news is helping the biopharmaceutical company start the week on a strong note.
Why Morphic, Athenex, Lixte Biotech Are Moving Today
01:02pm, Monday, 01'st Mar 2021
Morphic Holding Inc (NASDAQ: MORF), Athenex Inc (NASDAQ: ATNX) and Lixte Biotechnology Holdings Inc (NASDAQ: LIXT) are among the healthcare movers on Monday. Morphic Jumps On Data: Morphic, a biopharm
MORF Stock: Why Little-Known Morphic Holdings Is Up 100% Today
12:30pm, Monday, 01'st Mar 2021
Little-known MORF stock is rocketing higher after Morphic Holdings shared positive interim data from a Phase 1 clinical trial. The post MORF Stock: Why Little-Known Morphic Holdings Is Up 100% Today a
MORF Stock Price Increases Over 100% Intraday: Why It Happened
11:12am, Monday, 01'st Mar 2021
The stock price of Morphic Holding Inc (NASDAQ: MORF) has increased by over 100% during intraday trading as of 11 AM ET. This is why it happened.
Morphic Holding, Inc. (MORF) Reports Q4 Loss, Misses Revenue Estimates
09:07am, Monday, 01'st Mar 2021
Morphic Holding, Inc. (MORF) delivered earnings and revenue surprises of -54.05% and -26.24%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the st
Morphic Reports Positive Interim Results from Single Ascending Dose Phase 1 Clinical Trial of MORF-057
07:00am, Monday, 01'st Mar 2021
MORF-057 well tolerated in all dose cohorts
Morphic Announces Corporate Highlights and Financial Results for the Full Year 2020
06:55am, Monday, 01'st Mar 2021
Announced positive preliminary results from Phase 1 SAD clinical trial of MORF-057
Morphic Therapeutic to Participate in GI/Microbiome Panel Discussion at the 41st Annual Cowen Health Care Conference
04:05pm, Tuesday, 16'th Feb 2021
WALTHAM, Mass., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious ch
Morphic Expands Research and Development Collaboration with Janssen Through Third Integrin Program
08:00am, Tuesday, 05'th Jan 2021
New program demonstrates breadth of MInT platform with the inclusion of activating antibodies against integrin targets New program demonstrates breadth of MInT platform with the inclusion of activatin
Analyst talks Biotech sector, offers three picks for 2021
10:31am, Wednesday, 30'th Dec 2020
The biotechnology exchange-traded fund SPDR S&P Biotech ETF (NYSE: XBI) is up around 50% in 2020 and Jefferies' managing director Michael Yee says the valuations are not only justified but sustainable
